FDA Investigator: Scott N. Lim

- Scott N. Lim first started conducting FDA inspections in 2018, with the last inspection in 2024. Over that time, Scott N. Lim has conducted 58 inspections at 56 companies across 56 sites.

Get Scott Lim's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Comparative Biosciences, Inc, Sunnyvale | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 St. Helena Hospital IRB, Saint Helena | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Joshua D. Woolley, M.D., San Francisco | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Celltrion Inc., Yeonsu | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Sally Arai, M.D., Stanford | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Hawthorne Effect, Inc., Lafayette | 2024

Out-of-stock
Scott N. Lim
Medical Devices & Rad Health Form 483

FDA 483 Gilead Sciences Inc, Foster City | 2024

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Beigene USA, Inc., San Mateo | 2023

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Samsung Bioepis Co., Ltd, Yeonsu | 2023

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Genentech, Inc., South San Francisco | 2023

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Ardelyx, Inc., Fremont | 2023

Out-of-stock
Scott N. Lim
Human Drugs Form 483

FDA 483 Nezabravka Petrova Haytova, Vratsa | 2022

Out-of-stock
Scott N. Lim
Human Drugs Form 483